Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-05-24
2005-05-24
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S343000, C514S381000, C514S397000, C514S406000, C514S422000, C546S276400, C548S250000, C548S314700, C548S364100, C548S517000, C548S518000, C548S567000
Reexamination Certificate
active
06897234
ABSTRACT:
The present application describes modulators of CCR3 of formula (I):or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
REFERENCES:
patent: 3461120 (1969-08-01), Zenitz et al.
patent: 5668151 (1997-09-01), Poindexter et al.
patent: 5688955 (1997-11-01), Kruse et al.
patent: 5994369 (1999-11-01), Kolassa et al.
patent: 6331541 (2001-12-01), Ko et al.
patent: 6331545 (2001-12-01), Ko et al.
patent: 6441001 (2002-08-01), Watson et al.
patent: 6444686 (2002-09-01), Ko et al.
patent: 0350309 (1990-01-01), None
patent: 0747357 (1996-12-01), None
patent: 0903349 (1999-03-01), None
patent: 9320099 (1993-10-01), None
patent: 9422846 (1994-10-01), None
patent: 9427991 (1994-12-01), None
patent: 9427992 (1994-12-01), None
patent: 9519344 (1995-07-01), None
patent: 9717954 (1997-05-01), None
patent: 9722597 (1997-06-01), None
patent: 9727752 (1997-08-01), None
patent: WO 9728799 (1997-08-01), None
patent: 9738665 (1997-10-01), None
patent: 9825604 (1998-06-01), None
patent: 9825617 (1998-06-01), None
patent: 9831364 (1998-07-01), None
patent: 9964394 (1999-12-01), None
patent: 9967204 (1999-12-01), None
patent: WO 9967204 (1999-12-01), None
Stedman's medical dictionary “inflammation”(2000).*
Cohen et al. “Cuytokine function: a study in biologic diversity” CA 125:31527 (1996).*
Decosta et al., Synthesis and Evaluation of N-Substituted Cis-N-Methyl-2-(1-Pyrrolidinyl) Cyclohyxylamines as High Affinity Receptor Ligands, J. Med. Chem., 1990, pp. 3100-3110.
Kim et al., Migration and Proliferation of Guinea Pig and Human Airway Epithelial Cells in Response to Tachykinins, Am. J. Physiol., 1995, pp. 119-126, vol. 269.
Kraneveld et al., Airway Hyperresponsiveness; First Eosinophilis and Then Neuropeptides, Int. J. Immunopharmacol., 1998, pp. 517-527, vol. 19 (9/10).
DeLucca George
Duncia John
Kim Ui Tae
Ko Soo
Santella III Joseph B.
Bristol-Myers Squibb Pharma Company
Chang Celia
VanAtten Mary
LandOfFree
N-ureidoalkyl-piperidines as modulators of chemokine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-ureidoalkyl-piperidines as modulators of chemokine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-ureidoalkyl-piperidines as modulators of chemokine... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3438136